Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 386 of 6351
-
Virtual heart team aims to close medication gap for veterans with heart failure
Disease control Not yet recruitingMany Veterans who are hospitalized with heart failure do not receive all the recommended heart medications at the right doses before they leave the hospital or in the weeks following discharge. This study tests whether a team of clinical pharmacists and cardiologists, working vir…
Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
New model aims to forecast dementia risk in stroke survivors using genetics and brain imaging.
Knowledge-focused Recruiting nowTo collect large-scale multimodal data, including genomic information, neuroimaging, neurophysiological measures, cognitive assessments, and clinical characteristics from stroke survivors and healthy controls. This study aims to develop and validate an integrated prediction mode…
Sponsor: Seyoung Shin • Aim: Knowledge-focused
Last updated Jul 31, 2026 00:00 UTC
-
Can a new PET tracer light up hidden cancers?
Diagnosis Recruiting nowThis prospective, single-center, open-label exploratory diagnostic study aims to evaluate the safety, feasibility, and diagnostic performance of the novel Sortilin-targeted PET tracer 68Ga-SorB in patients with solid tumors. Eligible participants with confirmed or suspected melan…
Sponsor: Peking University Third Hospital • Aim: Diagnosis
Last updated Aug 14, 2026 00:00 UTC
-
New drug cocktail aims to boost lung cancer surgery success
Disease control Recruiting nowThis trial is a registrational Phase II/III, randomized, open-label, multicenter study to evaluate the efficacy and safety of BL-B01D1 in combination with osimertinib in resectable EGFR-mutant non-small cell lung cancer.
Phase 2/3 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
New weight loss pill HRS9531 enters final testing phase
Disease control Recruiting nowThis study aims to evaluate the efficacy and safety of HRS9531 tablets compared with placebo in reducing body weight in overweight or obese subjects after 52 weeks of treatment.
Phase 3 • Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
New eye drug targets fluid buildup to fight glaucoma
Disease control Not yet recruitingThis study will test an experimental drug called REGN22530 ("study drug") to see if it can help treat people with primary open angle glaucoma or ocular hypertension. REGN22530 is an experimental drug that is designed to bind with a protein in the eye that has been shown to cause …
Phase 1/2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New pill shows promise for teens with rare brain cancer
Disease control Recruiting nowThe objective of this study is to evaluate the safety, tolerability, efficacy profile, and effect on growth and development of vorasidenib in pediatric participants aged 12 to \< 18 years old with grade 2 glioma with an IDH1 or IDH2 mutation. The study includes a screening period…
Phase 2 • Sponsor: Institut de Recherches Internationales Servier (I.R.I.S.) • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Can an updated COVID-19 vaccine keep up with the virus?
Vaccine Recruiting nowThe purpose of this study is to learn about the safety and effects of an updated COVID-19 vaccine (called BNT162b2) in adults 18 to 64 years of age. This study is seeking participants who: * are medically stable * have not had a recent COVID-19 infection * have not had a recent…
Phase 4 • Sponsor: BioNTech SE • Aim: Vaccine
Last updated Aug 09, 2026 00:00 UTC
-
Stool test duo could revolutionize cancer surveillance in colitis
Diagnosis Not yet recruitingUlcerative colitis (UC) is a chronic inflammatory bowel disease associated with an increased risk of colorectal cancer, known as UC-associated neoplasia (UCAN). Current guidelines recommend regular colonoscopy surveillance for long-standing UC patients, but this strategy faces ch…
Sponsor: Qilu Hospital of Shandong University • Aim: Diagnosis
Last updated Aug 05, 2026 00:00 UTC
-
A simple blood pressure cuff trick could shield the heart in kidney disease
Disease control Recruiting nowThe aim of our study is to evaluate the impact of repeated episodes of ischemic quenching on changes in blood pressure, heart rate and laboratory parameters of inflammation in patients with kidney diseases. There is credible evidence that intentionally producing periods of ischem…
Sponsor: Medical University of Lodz • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Can a new drug tackle Hard-to-Treat gynecologic cancers?
Disease control Recruiting nowThis is a Phase 1 study to assess safety, tolerability, pharmacokinetics, immunogenicity, and antitumor activity of ARR-002 in advanced or metastatic ovarian or endometrial cancer.
Phase 1 • Sponsor: ArriVent BioPharma, Inc. • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Can AI predict complications before they happen during sedation?
Knowledge-focused Recruiting nowThe SED-PACK study is a prospective, observational, single-center clinical investigation evaluating the clinical performance and safety of SED Pack, a Medical Device Software (MDSW) developed by Predictheon Medical S.L., in a fully blinded, non-interventional setting during routi…
Sponsor: Predictheon Medical, S.L. • Aim: Knowledge-focused
Last updated Aug 08, 2026 00:03 UTC
-
Can a gentler root canal save more tooth and still heal infection?
Disease control Not yet recruitingStatement of the problem: The effectiveness of minimally invasive endodontic treatments in managing necrotic pulp with apical periodontitis remains understudied. Aim of the study: This research aims to evaluate the outcomes of minimally invasive versus traditional root canal trea…
Phase 2/3 • Sponsor: Mohamed Ashraf Abdeen • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Which food prescription works best? a trial aims to find out
Disease control Recruiting nowThe goal of this clinical trial is to learn how to increase the usage and acceptability of Food Is Medicine programs among families with young children experiencing food insecurity who receive Medicaid benefits. Food Is Medicine programs connect food and nutrition programs to the…
Sponsor: State University of New York at Buffalo • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
Less invasive heart valve replacement put to the test against Open-Heart surgery
Disease control Recruiting nowThe study is a multicenter, randomized superiority trial of standard of care therapies for severe aortic stenosis (AS) in patients with a bicuspid aortic valve (BAV). The two primary comparators in this study are: Transcatheter Aortic Valve Replacement (TAVR), and Surgical Aorti…
Sponsor: Cedars-Sinai Medical Center • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
New drug candidate SHR-3079 targets Hard-to-Treat lymphoma
Disease control Recruiting nowThe study is being conducted to evaluate the safety and tolerability of SHR-3079, and to explore the Dose-limiting Toxicity (DLT), Maximum Tolerated Dose (MTD) and the Recommended Phase 2 Dose (RP2D). This study also preliminarily evaluated the efficacy of SHR-3079 in patients wi…
Phase 1 • Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Which PAH treatment strategy works better: adding a third drug or increasing the dose?
Disease control Recruiting nowPulmonary arterial hypertension (PAH) is a rare and progressive disease characterized by increased pressure in the pulmonary arteries, leading to right heart failure and premature death. Although combination therapy has improved outcomes, many patients remain at intermediate or h…
Phase 4 • Sponsor: University of Sao Paulo General Hospital • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
Could J147 help stroke patients recover better?
Disease control Recruiting nowThe goal of this clinical trial is to find out if the drug J147 improves outcomes for persons who have had an ischemic stroke. It also will learn about the safety of J147 when given by injection to stroke patients. Researchers will compare the outcomes of those who receive J147 a…
Phase 2 • Sponsor: Abrexa Pharmaceuticals, Inc. • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
New hope for lymphoma patients: glofitamab combo faces standard care in trial
Disease control Not yet recruitingThe purpose of this study is to evaluate the efficacy and safety of glofitamab in combination with gemcitabine plus oxaliplatin (GemOx) versus standard of care (SOC) in patients with relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL) who have relapsed early (within 1 y…
Phase 2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Can pressurized oxygen boost stroke recovery?
Disease control Recruiting now1. The goal of this clinical trial is to evaluate the efficacy and safety of hyperbaric oxygen (HBO)in stroke patients after endovascular treatment 2. The main questions it aims to answer is: Whether HBO can improve the prognosis of ischemic stroke patients after endovascular…
Sponsor: Beijing Chao Yang Hospital • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC